Breast Cancer Care in a COVID-19 Pandemic Epicenter

Wagner JL Warneke CL , et al. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011;254(1):119-124. doi:10.1097/SLA.0b013e318217e97f

Society of Surgical Oncology . Resource for management options of breast cancer during COVID-19. March 30, 2020. Available at: https://www.surgonc.org/wp-content/uploads/2020/03/Breast-Resource-during-COVID-19-3.30.20.pdf [Accessed on October 26, 2020].

Dietz JR Moran MS Isakoff SJ , et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487-497.

Fisher B Bauer M Margolese R , et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665-673. doi:10.1056/NEJM198503143121101

Giuliano AE Hunt KK Ballman KV , et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305(6):569-575. doi:10.1001/jama.2011.90

Mathews M Ryan D Gadag V West R . Patient satisfaction with wait-times for breast cancer surgery in Newfoundland and Labrador. Healthcare Policy. 2016;11(3):42-53.

The American Society of Breast Surgeons. COVID-19 registry, https://www.breastsurgeons.org/resources/covid19_registry [Accessed on October 26, 2020].